Medivir AB (publ) (STO:MVIR)

Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of SEK 1.16 billion. The enterprise value is 1.05 billion.

Market Cap	1.16B
Enterprise Value	1.05B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Medivir AB has 538.67 million shares outstanding. The number of shares has increased by 25.08% in one year.

Current Share Class	538.67M
Shares Outstanding	538.67M
Shares Change (YoY)	+25.08%
Shares Change (QoQ)	+97.86%
Owned by Insiders (%)	20.30%
Owned by Institutions (%)	4.74%
Float	296.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	136.25
PB Ratio	4.38
P/TBV Ratio	4.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.09
EV / Sales	123.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.03.

Current Ratio	3.66
Quick Ratio	3.66
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-51.67

Financial Efficiency

Return on equity (ROE) is -49.68% and return on invested capital (ROIC) is -92.03%.

Return on Equity (ROE)	-49.68%
Return on Assets (ROA)	-24.27%
Return on Invested Capital (ROIC)	-92.03%
Return on Capital Employed (ROCE)	-34.12%
Weighted Average Cost of Capital (WACC)	8.98%
Revenue Per Employee	850,000
Profits Per Employee	-9.44M
Employee Count	10
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.71% in the last 52 weeks. The beta is 0.85, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+38.71%
50-Day Moving Average	1.16
200-Day Moving Average	1.24
Relative Strength Index (RSI)	57.90
Average Volume (20 Days)	13,936,577

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of SEK 8.50 million and -94.40 million in losses. Loss per share was -0.66.

Revenue	8.50M
Gross Profit	-32.90M
Operating Income	-93.00M
Pretax Income	-94.40M
Net Income	-94.40M
EBITDA	-60.50M
EBIT	-93.00M
Loss Per Share	-0.66

Balance Sheet

The company has 119.20 million in cash and 8.20 million in debt, with a net cash position of 111.00 million or 0.21 per share.

Cash & Cash Equivalents	119.20M
Total Debt	8.20M
Net Cash	111.00M
Net Cash Per Share	0.21
Equity (Book Value)	264.50M
Book Value Per Share	0.59
Working Capital	89.90M

Cash Flow

Operating Cash Flow	-73.30M
Capital Expenditures	n/a
Depreciation & Amortization	32.50M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,094.12%
Pretax Margin	-1,110.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.08%
Shareholder Yield	-25.08%
Earnings Yield	-8.15%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -1.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.98
Piotroski F-Score	4